Abstract: Professor Dan Yan is funded by the National Science Fund for Outstanding Young Scholars and selected in National Talent Project. He is also the leader of Beijing High Innovation Plan and Top Team of Beijing Excellent Talent Project and the director of Beijing key laboratory. Given the current situation that the quality control of Chinese materia medica (CMM) is poorly associated with clinical efficacy, the applicant has established clinical bio-characteristic profiling and related series of key techniques for assessment of quality fluctuation in CMM and rationality in clinical joint drug administration.

Key words: quality evaluation of Chinese materia medica, clinical effect, clinical bio-characteristic profiling, rational drug use